JKJaeGoo Kim

JaeGoo Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


JaeGoo Kim has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trichosanthes kirilowii Extract Promotes Wound Healing through the Phosphorylation of ERK1/2 in Keratinocytes

    by Minho Kim, Jae-Goo Kim, Ki-Young Kim

    The proliferation of keratinocytes is one of the important steps in the wound-healing process, which is regulated by various signals. Prior studies have shown that Trichosanthes kirilowii extract has the ability to promote angiogenesis. Therefore, in this study, we tested the wound-healing efficacy of Trichosanthes kirilowii extract with respect to promoting keratinocyte proliferation. A total of 100 μg/mL of Trichosanthes kirilowii extract treatment improved 145.38% of keratinocyte proliferation compared with DMSO-treated control in an MTT assay and increased 238.2% of wound closure by re-epithelialization in an in vitro wound-healing assay. Trichosanthes kirilowii extract promoted ERK1/2 phosphorylation in western blot analysis and induced the expression of the c-fos and c-jun (AP-1 transcription factors), cyclins (cell cycle regulator), and growth factors CTGF and VEGF (stimulator of angiogenesis) in qRT-PCR analysis. An in vivo wound-healing assay showed that Trichosanthes kirilowii extract improved wound healing, and the significant difference in wound closure compared with DMSO-treated control was shown on days 6 and 7 with a mouse model. Taken together, we demonstrate that Trichosanthes kirilowii extract promotes the proliferation of keratinocytes by activating ERK1/2 and increasing the mRNA expression of c-fos, c-jun, CTGF, and VEGF. Therefore, we suggest Trichosanthes kirilowii extract as a new component for skin care and as a wound-healing substance.


  • Antibacterial activity of pimaric acid against the causative agent of American foulbrood, Paenibacillus larvae

    by Hyunchan Song, Jaegoo Kim, Yu-Kyong Shin, Ki-Young Kim

    The number of bees has decreased drastically partly due to bacterial pathogens like Paenibacillus larvae that cause American foulbrood disease. The recent emergence of pathogenic resistant strains makes it more difficult to, successfully, treat infections. Research on alternative antibacterial agents from naturally occurring plants that also have low toxicity levels is critical to address the issue of Paenibacillus larvae in bee colonies. Five compounds were screened with a minimal inhibitory concentration (MIC) test in order to identify a compound with effective antibacterial activity against Paenibacillus larvae. Of the tested compounds, pimaric acid showed the best antibacterial activity with a MIC value of 6.25 µg/ml after 48 hours of incubation on MYPGP media. An agar diffusion test also confirmed the anti- Paenibacillus larvae activity of pimaric acid with an inhibitory zone of 10 to 14 mm. Crystal violet assay results suggested that pimaric acid disrupted the plasma membrane of Paenibacillus larvae, causing the leakage of material with an optical density of 260-nm and 280-nm, which confirmed that the compound induces the rupture of this microorganism. Pimaric acid inhibited the formation of a Paenibacillus larvae biofilm in a dose-dependent manner. An additive effect of pimaric acid with tetracycline and terramycin was shown through a checkerboard assay with a fractional inhibitory concentration (FIC) index value of 0.75. Finally, an MTT assay on insect cells of Trichoplusia ni and normal human skin cells from the HaCaT cell line, showed that pimaric acid is safe for both insect cell and human skin cells at the dosage required to treat Paenibacillus larvae.


  • Antimicrobial activity of 4-hydroxyderricin, sophoraflavanone G, acetylshikonin, and kurarinone against the bee pathogenic bacteria Paenibacillus larvae and Melissococcus plutonius

    by Sangchul Park, JaeGoo Kim, Yu-Kyong Shin, Ki-Young Kim

    The global number of bees has recently declined. One reason is pathogenic microorganisms including Paenibacillus larvae, which causes American foulbrood disease, and Melissococcus plutonius, which causes European foulbrood disease. The aim of this study was to identify new antimicrobial agents against foulbrood disease. Broth-microdilution assays with 20 natural compounds were used to detect the in vitro antimicrobial activity against foulbrood disease, and MTT assays were performed to determine cytotoxicity against a human cell line. 4-Hydroxydericin, sophoraflavanone G, acetylshikonin, and kurarinone were found to have antimicrobial activity against P. larvae and M. plutonius, with less cytotoxicity against HaCaT cells. In addition, these compounds have a synergic effect with tetracycline or macelignan, which could potentially be effective to control foulbrood disease of honey bees.


  • Open Access

    Promotion of Keratinocyte Proliferation by Tracheloside through ERK1/2 Stimulation

    by JaeGoo Kim, Yu-Kyong Shin, Ki-Young Kim

    Cell migration and proliferation are important for proper wound healing after skin injury. Recent studies have shown that compounds from plants could promote cell migration and proliferation. Tracheloside, which is a plant lignan, has been found to promote the growth of HaCaT cells over 40% compared to other compounds tested based on a cell proliferation assay. Anin vitroscratch assay confirmed the healing activity of tracheloside (more than 2‐fold increased healing activity after 24 hours of treatment compared with the control) and revealed that this activity is better than that of allantoin (1.2‐fold increased after 24 hours of treatment compared with the control), a positive control. With western blot results, wound healing with tracheloside occurred through the phosphorylation of ERK1/2. Therefore, tracheloside is a good candidate to promote wound healing and could be developed as a therapeutic agent for wound treatment or used as a leading compound with higher activity.